Brief: Stayble Therapeutics Gets Approval To Start Phase 1b Study

Stayble Therapeutics AB

28/02/2023 14:23

Feb 28 (Reuters) - Stayble Therapeutics AB  STABL.ST :
    * RECEIVES APPROVAL TO START A PHASE IB CLINICAL TRIAL WITH
STA363
FOR THE TREATMENT OF HERNIATED DISCS
    * PHASE 1B STUDY WILL BE CONDUCTED IN POLAND, IN
COLLABORATION
WITH CROMSOURCE

Source text for Eikon:  ID:nWkrbjvQzJ 
Further company coverage:  STABL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))